Introduction {#s1}
============

Feeding behavior rarely occurs as a direct result of an immediate metabolic or nutrient deficiency. Rather, most animals (including humans) have habitual feeding patterns, consuming a fixed number of meals at approximately the same time each day. Environmental stimuli associated with learned meal anticipation elicit preparatory biological 'cephalic' responses (e.g., pancreatic insulin release) that occur prior to food consumption ([@bib79]; [@bib78]). These types of conditioned biological responses are advantageous when environmental factors place constraints on eating (e.g., predator threat, limited periods of food availability, and social or professional obligations) because they promote consumption of a large quantity of food within a relatively short time period. One important biological signal associated with conditioned appetite and feeding is ghrelin, a hormone derived from P/D1 cells in the stomach that is the only known circulating hormone that increases food intake([@bib76]; [@bib14]). While often referred to as a 'hunger' hormone, ghrelin is perhaps more aptly described as a meal-anticipatory hormone based on findings from both humans and rodents showing that ghrelin levels rise before an anticipated feeding bout independent of energy deprivation levels ([@bib22]; [@bib15]; [@bib20]). Genetic deletion of the ghrelin receptor (growth hormone secretagogue receptor 1A; GHSR) eliminates food anticipatory activity under meal entrainment feeding schedules([@bib5]; [@bib17]), further supporting the notion that ghrelin acts as a conditioned meal-anticipatory signal.

The mechanisms through which ghrelin communicates with the central nervous system to control learned aspects of food intake regulation are poorly understood. The hippocampus is a brain region historically associated with visuospatial and episodic memory function that has more recently been linked with the control of various feeding-relevant behaviors ([@bib3]; [@bib16]; [@bib38]; [@bib50]), including conditioned meal anticipation ([@bib58]; [@bib34]; [@bib32]). GHSR is expressed abundantly in hippocampal neurons ([@bib43]), and we recently demonstrated that pharmacological activation of GHSR by ghrelin in ventral/temporal subregions of the hippocampus (vHP) potently stimulates food intake by increasing both meal frequency and meal size ([@bib37]). However, the extent to which endogenous vHP GHSR signaling controls conditioned anticipatory feeding behavior has not been investigated.

The lateral hypothalamic area (LHA) is implicated in the control of fundamental motivated behaviors, including food intake (For review see: \[[@bib67]; [@bib41]; [@bib4]\]). Classic studies show that LHA electrical ablation results in profound hypophagia ([@bib71]; [@bib2]), whereas LHA electrical stimulation robustly increases food intake ([@bib19]). The LHA has direct connections with brain regions involved in the regulation of energy balance, including the hypothalamic arcuate and paraventricular nuclei ([@bib28]), and the medial nucleus of the solitary tract ([@bib12]). In addition, the LHA is also directly connected with several brain regions that regulate 'higher-order' cognitive aspects of feeding behavior, including the vHP, amygdala, nucleus accumbens (ACB), and ventral tegmental area (VTA) ([@bib28]; [@bib26]; [@bib8]; [@bib27]; [@bib24]). Of note, vHP pyramidal neurons in field CA1 and the subiculum are a major source of direct and exclusively ipsilateral input to the LHA, especially the dorsal perifornical LHA (dpLHA) ([@bib28]; [@bib8]; [@bib27]; [@bib39]). The dpLHA also has abundant expression of the neuropeptide orexin (ORX/hypocretin) ([@bib68]; [@bib26]), which in addition to an established role in behavioral arousal ([@bib25]; [@bib10]), also has a central orexigenic role in the control of ingestive behavior ([@bib77]; [@bib60]; [@bib62]; [@bib72]; [@bib70]; [@bib49]). We hypothesize that LHA ORX neurons are a critical downstream substrate of vHP ghrelinergic appetitive neural responding, because \[1\] orexin receptor 1 (Ox1R) signaling is required for ventricular ghrelin-induced hyperphagia ([@bib13]), and \[2\] LHA ORX neurons are activated in anticipation of feeding under meal entrainment schedules ([@bib36]).

In the present study we investigate the neural substrates through which ghrelin communicates conditioned appetite and feeding behavior to and within the brain. We hypothesize the existence of a neural pathway whereby peripherally-derived ghrelin (secreted in anticipation of feeding) activates GHSR-expressing vHP glutamatergic (pyramidal) neurons, which in turn activate orexin-expressing dpLHA neurons to stimulate appetite and feeding via CNS Ox1R signaling. We employed a combination of methods to facilitate a correlative approach, including neural pathway-tracing, immunohistochemistry, behavioral neuropharmacology, meal entrainment conditioning, and excitotoxic unilateral lesion-mediated neural 'disconnection' between pharmacological vHP GHSR activation and the dpLHA. The results of these experiments suggest novel mechanisms linking mnemonic processes with gut-brain communication to control feeding behavior.

Results {#s2}
=======

Endogenous ghrelin signaling in vHP neurons promotes conditioned feeding behavior {#s2-1}
---------------------------------------------------------------------------------

[Figure 1](#fig1){ref-type="fig"} depicts a representative 100nl vHP injection site. Rats restricted to 4 hr chow access per day (meal entrainment schedule) learned to gradually increase their chow consumption over the 8 day training period (significant main effect of Day, p\<0.01) ([Figure 2A](#fig2){ref-type="fig"}). Bilateral parenchymal delivery of the selective GHSR antagonist, JMV2959 (10 μg) to vHP neurons significantly reduced 4 hr chow intake in meal-entrained rats (p\<0.05; [Figure 2B](#fig2){ref-type="fig"}). However, the same dose of JMV2959 had no effect on 4 hr rebound feeding following 20 hr food restriction in control rats that were not meal entrained ([Figure 2C](#fig2){ref-type="fig"}). Moreover, the JMV2959-induced intake reduction observed in meal-entrained rats appears to be specific to conditioned feeding behavior as opposed to being based on higher baseline kcal consumption in meal entrained vs. control rats. This is supported by results showing that vHP JMV2959 administration did not reduce 4 hr Western diet intake in non-meal entrained, non-food restricted rats under conditions in which total kcal intake exceeded levels observed in meal-entrained rats ([Figure 2D](#fig2){ref-type="fig"}). Collectively these findings indicate that endogenous vHP ghrelin signaling is critical in the control of conditioned feeding behavior.10.7554/eLife.11190.003Figure 1.Representative vHP injection site is shown as localization of pontamine sky blue ink following a 100 nl injection.CA1sp, CA3sp: CA1 and CA3 pyramidal cells; alv = alveus.**DOI:** [http://dx.doi.org/10.7554/eLife.11190.003](10.7554/eLife.11190.003)10.7554/eLife.11190.004Figure 2.Effects of vHP GHSR blockade on conditioned food intake. (**A**) Daily 4 hr chow intake during meal entrainment acquisition, where animals were limited to 4 hr food intake/day for 8 days. (**B**) 4 hr chow intake in meal-entrained animals following bilateral vHP administration of JMV2959. (**C**) 4 hr chow intake in non-meal entrained, 20 hr food-restricted rats following bilateral vHP administration of JMV2959. (**D**) 4 hr Western diet intake in non-meal entrained, non-food deprived rats following bilateral vHP administration of JMV2959. Data are mean ± SEM; \*p\<0.05.**DOI:** [http://dx.doi.org/10.7554/eLife.11190.004](10.7554/eLife.11190.004)10.7554/eLife.11190.005Figure 2---figure supplement 1.Effects of LHA GHSR blockade on conditioned food intake. (**A**) Daily 4 hr chow intake during meal entrainment acquisition. (**B**) 4 hr chow intake in meal-entrained animals following bilateral LHA administration of JMV2959. (**C**) 4 hr chow intake in non-meal entrained, 20 hr food-restricted rats following bilateral LHA administration of JMV2959. Data are mean ± SEM.**DOI:** [http://dx.doi.org/10.7554/eLife.11190.005](10.7554/eLife.11190.005)

Endogenous ghrelin signaling in LHA neurons does not regulate conditioned feeding behavior {#s2-2}
------------------------------------------------------------------------------------------

Like the vHP, the LHA is another brain region that expresses GHSR, and activation of these receptors increases feeding ([@bib43]; [@bib48]), Moreover, orexin-producing neurons in the LHA are activated by external food-related cues and by LHA administration of ghrelin ([@bib48]; [@bib55]). Thus, to determine whether endogenous LHA ghrelin signaling also contributes to conditioned feeding responses, we repeated the meal entrainment and non-entrained, 20 hr food deprivation procedures in LHA cannulated rats. Animals restricted to 4 hr chow access per day again learned to increase their chow consumption over the 8 day training period (significant main effect of Day, p\<0.01) ([Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}). Bilateral delivery of JMV2959 had no effect on 4 hr chow intake in meal entrained rats, nor did LHA JMV2959 application influence 4 hr chow intake in 20 hr food deprived, non-meal entrained rats ([Figure 2---figure supplement 1B,C](#fig2s1){ref-type="fig"}). These findings suggest that unlike vHP ghrelin signaling, LHA ghrelin signaling does appear to be critical for the manifestation of conditioned feeding behavior.

GHSR-expressing vHP CA1 neurons provide input to dpLHA neurons {#s2-3}
--------------------------------------------------------------

A vHP to LHA pathway hypothesized to play a role in GHSR signaling for the control of conditioned feeding behavior, was investigated using retrograde pathway-tracing and immunohistochemistry. Following injection of either Fluorogold or cholera toxin B subunit (CTB) into the dpLHA, abundant exclusively ipsilateral retrograde labeling was seen in the vHP field CA1 and subiculum (i.e., no Fluorogold- or CTB-immunoreactive cells were observed in the ventral CA1 contralateral to tracer injections), consistent with previous findings ([@bib26]; [@bib27]; [@bib8]). Further investigation of CTB and Fluorogold retrogradely-labeled vHP neurons found that most were also immunoreactive for GHSR \[representative dpLHA CTB injection site depicted in [Figure 3A](#fig3){ref-type="fig"}; retrogradely-labeled CTB immunoreactive soma in the vHP depicted in [Figure 3C](#fig3){ref-type="fig"}; inset location delineated in [Figure 3B](#fig3){ref-type="fig"}\]. Consistent with previous literature revealing extensive GHSR mRNA expression in the vHP CA fields ([@bib43]; [@bib82]), our immunohistochemistry analyses confirmed robust GHSR protein expression in vHP CA1 pyramidal neurons ([Figure 3D](#fig3){ref-type="fig"}). Quantification of the percentage of back-labeled CTB and Fluorogold immunoreactive soma also expressing GHSR revealed 84.11% (SEM = 0.07) colocalization in rats injected with CTB in the LHA, and 86.22% (SEM = 0.03) colocalization in rats that were injected with Fluorogold  in the LHA (representative CTB and GHSR co-labeled soma depicted in [Figure 2E](#fig2){ref-type="fig"}). These data indicate that the vast majority of vHP neurons that provide an ipsilateral input to the dpLHA also express GHSR.10.7554/eLife.11190.006Figure 3.GHSR-expressing vHP CA1 neurons provide input to dpLHA neurons.(**A**) A representative dorsal perifornical LHA injection site of CTB-AF594 (red). fx:fornix; V3h: Third ventricle (**B**) Darkfield cytoarchitecture of the vHP, where insets C-E represents field CA1 pyramidal layer (CA1sp) insets from the square (white dashed line). (**C**) vHP retrogradely-labeled CTB immunoreactive perikarya (red). (D) GHSR protein expression (green). (**E**) CTB and GHSR co-labeled soma.**DOI:** [http://dx.doi.org/10.7554/eLife.11190.006](10.7554/eLife.11190.006)

Unilateral LHA lesions block the hyperphagic response following GHSR activation in ipsilateral, but not contralateral vHP neurons {#s2-4}
---------------------------------------------------------------------------------------------------------------------------------

To explore the functional relevance of the exclusively unilateral vHP to dpLHA communication in vHP ghrelin-mediated hyperphagia, rats with unilateral excitotoxic (NMDA) or sham lesions in the dpLHA were implanted with bilateral vHP-targeted cannulae (representative unilateral dpLHA lesion depicted in [Figure 4](#fig4){ref-type="fig"} with NeuN immunohistochemistry). Food intake was measured after unilateral vHP administration of ghrelin (300 pmol) to rats with dpLHA lesions or sham lesions that were either ipsilateral or contralateral to the side of ghrelin administration (i.e. vHP to LHA communication either eliminated or intact). Ghrelin delivered to the vHP contralateral to the LHA lesion (or sham lesion) significantly increased chow intake in both groups, whereas ghrelin delivered to the vHP ipsilateral to the LHA lesion (or sham lesion) significantly increased food intake only in the Sham group ([Figure 5A--D](#fig5){ref-type="fig"}; \*indicates p\<0.05 vs. vehicle treatment, **Ŧ** indicates p\<0.07 vs. vehicle treatment). A repeated-measures overall ANOVA was also performed with 'lesion group' as a between subjects variable and 'drug' as a repeated measures variable. There was no overall significant 'group' effect on food intake at any point, whereas the overall 'drug' effect was significant at all time points (p\<0.001). Furthermore, there was a significant interaction between 'group' and 'drug' at the 5 hr time point \[F(1,15)=4.93, p\<0.05\], whereas this interaction just missed significance at the 1 hr and 3 hr time points. These results show that vHP neural communication with the dpLHA is required for vHP ghrelin-mediated feeding effects.10.7554/eLife.11190.007Figure 4.Representative unilateral dpLHA lesions.(**A**) NeuN immunohistochemistry contralateral to a NMDA dorsal perifornical (dp) LHA lesion (intact side). (**B**) NeuN immunohistochemistry for a representative unilateral NMDA dpLHA lesion targeting the dorsal perifornical LHA.**DOI:** [http://dx.doi.org/10.7554/eLife.11190.007](10.7554/eLife.11190.007)10.7554/eLife.11190.008Figure 5.Effects of vHP-dpLHA unilateral disconnection on vHP ghrelin-mediated hyperphagia.Cumulative chow intake following unilateral vHP injections of ghrelin (300 pmol) that was: (**A**) Ipsilateral to a unilateral dpLHA lesion, (**B**) ipsilateral to a dpLHA sham lesion. (**C**) contralateral to a dpLHA lesion, and (**D**) contralateral to a dpLHA sham lesion. Data are mean ± SEM; \*p\<0.05; Ŧ p\<0.07.**DOI:** [http://dx.doi.org/10.7554/eLife.11190.008](10.7554/eLife.11190.008)

vHP CA1 neurons provide input to dpLHA ORX-expressing neurons {#s2-5}
-------------------------------------------------------------

Anterograde pathway-tracing with *Phaseolus vulgaris* leucoagglutinin (PHAL) provided further support for a direct and exclusively ipsilateral connection from the vHP to the dpLHA ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"} displays PHAL immunoreactive axons that are exclusively ipsilateral to a vHP PHAL iontophoresis injection). PHAL was injected by iontophoresis into the vHP field CA1 (representative injection site depicted in [Figure 6A](#fig6){ref-type="fig"}). Double-label immunohistochemistry for PHAL and ORX revealed several instances of PHAL-labeled axons with numerous varicosities in close apposition to ORX-expressing neurons within the dpLHA (representative examples shown in [Figure 6C](#fig6){ref-type="fig"}, inset location delineated in [Figure 6B](#fig6){ref-type="fig"}). Subsequent triple-label immunohistochemistry for PHAL, ORX, and the presynaptic marker synaptophysin indicated that the apparent terminal appositions were putative sites of synaptic input from vHP CA1 neurons to ORX-expressing neurons (representative examples shown in [Figure 6D](#fig6){ref-type="fig"}). These data confirm an input to the dpLHA from the vHP field CA1, and indicate further that this input targets ORX-expressing neurons.10.7554/eLife.11190.009Figure 6.vHP CA1 neurons provide input to dpLHA ORX-expressing neurons.(**A**) A representative PHAL (blue) injection site centered in ventral hippocampus field CA1. CA1sp, CA3sp: CA1 and CA3 pyramidal cells. (**B**) Darkfield microscopy, where neuroanatomical analyses were performed in the dpLHA (fx: fornix; V3h: Third ventricle; location shown in C). Inset (**C**) confocal imaging reveals some orexin neurons (red) in the dpLHA that are in close apposition to vHP field CA1-originating axons, labeled with PHAL (blue). (**D**) Triple-label imaging reveals co-labeling of PHAL and synaptophysin (green) in axons in apposition to dpLHA orexin-expressing soma (indicated by white arrows).**DOI:** [http://dx.doi.org/10.7554/eLife.11190.009](10.7554/eLife.11190.009)10.7554/eLife.11190.010Figure 6---figure supplement 1.CA1 vHP neurons project ipsilaterally to the dpLHA.(**A--C**) PHAL-immunoreactive axons originating from the vHP (field CA1) within the dpLHA, revealing an exclusively ipsilateral projection from the vHP to the dpLHA (v3h = 3rd ventricle; fx = fornix).**DOI:** [http://dx.doi.org/10.7554/eLife.11190.010](10.7554/eLife.11190.010)

vHP GHSR activation increases expression of Fos in dpLHA ORX-expressing neurons {#s2-6}
-------------------------------------------------------------------------------

Unilateral vHP ghrelin (300 pmol) administration robustly increased expression of the neural activation marker Fos in the ipsilateral LHA compared to vehicle treatment (p\<0.01 vs. vehicle and vs. contralateral LHA). Notably, vHP ghrelin injection activated approximately 70% of orexin-expressing neurons in the ipsilateral LHA ([Figure 7](#fig7){ref-type="fig"}; p\<0.01 compared to vehicle treatment). These data are consistent with the hypothesis that vHP ghrelin signaling activates orexin-expressing dpLHA neurons.10.7554/eLife.11190.011Figure 7.vHP GHSR activation increases Fos expression in dpLHA orexin-expressing neurons. (**A**) Orexin-expressing neurons (red) in the dpLHA; fx: fornix.  (**B**) Fos expression (green) in the dpLHA induced by ipsilateral vHP ghrelin (300 pmol) administration. (**C**) Co-labeling of dpLHA orexin expression and Fos expression. (**D**) Quantification of orexin positive soma co-labeled with Fos, where co-labeling was significantly higher compared to vHP vehicle injections. Data are mean ± SEM; \*p\<0.05.**DOI:** [http://dx.doi.org/10.7554/eLife.11190.011](10.7554/eLife.11190.011)

Central blockade of Ox1R eliminates vHP ghrelin-mediated hyperphagia {#s2-7}
--------------------------------------------------------------------

To test whether vHP ghrelin-mediated hyperphagia requires downstream Ox1R signaling, rats first received a lateral ventricle (LV) injection of either vehicle (DMSO) or the Ox1R antagonist, SB334867, at a dose (30 nmol) that was subthreshold for intake effects alone under these conditions. Immediately afterwards, the rats received unilateral parenchymal vHP injections of ghrelin (300 pmol) or vehicle on separate test days. Treatments were counter-balanced using a within-subjects design. Ghrelin significantly increased chow intake in rats pretreated with vehicle in the LV, but had no effect relative to vehicle on intake in rats pretreated with SB334867 ([Figure 8A,B](#fig8){ref-type="fig"}; \*indicates p\<0.05 vs. vehicle treatment, **Ŧ** indicates p\<0.07 vs. vehicle treatment). These data indicate that vHP-mediated feeding effects involve downstream Ox1R signaling.10.7554/eLife.11190.012Figure 8.Effects of Orexin-1 receptor blockade on ghrelin-mediated hyperphagia. Cumulative chow intake following: (**A**) pre-treatment with lateral ventricle (LV) vehicle followed by vHP ghrelin (300 pmol, unilateral) administration or (**B**) LV Ox1R antagonist, SB334867 (30 nmol), followed by vHP ghrelin administration. Data are mean ± SEM; \*p\<0.05; Ŧ p\<0.07.**DOI:** [http://dx.doi.org/10.7554/eLife.11190.012](10.7554/eLife.11190.012)

Discussion {#s3}
==========

Ghrelin levels rise in anticipation of feeding ([@bib22]; [@bib15]; [@bib20]) and ghrelin receptor null mice show blunted meal anticipatory responding under meal entrainment feeding schedules ([@bib5]; [@bib17]). Compared to equivalent levels of food restriction, the anticipation of eating in meal entrained rats had a greater stimulatory effect on ghrelin release ([@bib20]), indicating that ghrelin acts as a meal anticipation hormonal signal that facilitates the consumption of large quantities of food. This notion is also consistent with data showing a role for ghrelin in stimulating gastric motility ([@bib45]; [@bib53]) and increasing meal size ([@bib37]; [@bib40]; [@bib69]; [@bib18]; [@bib21]). Here we identify and characterize a novel neural substrate extending these previous findings by demonstrating that vHP ghrelin signaling is physiologically relevant for conditioned feeding behavior. After exposure to a meal entrainment schedule in which rats were restricted to 4 hr food access each day, pharmacological blockade of vHP GHSR signaling prior to food access significantly reduced 4 hr chow consumption. Comparatively, vHP GHSR blockade had no effect on a 4 hr chow intake in equally food-restricted rats that had not undergone the meal entrainment learning. Moreover, the intake reduction appears to be specific to conditioned feeding behavior as opposed to being based on higher baseline kcal consumption in meal entrained vs. control rats. This is supported by results showing that vHP JMV2959 administration did not reduce Western diet intake in non-food deprived, non-meal entrained animals under conditions where baseline kcal intake of the Western diet was actually higher than in meal-entrained rats consuming chow. However, another study showed that peripheral GHSR antagonist (Compound 26) delivery failed to suppress feeding in meal-entrained mice ([@bib54]), yet we note that this previous study utilized a different GHSR antagonist, a different species, and a different route of administration (peripheral). Collectively, these findings build on previous work showing that pharmacological vHP GHSR activation increases meal frequency and size ([@bib37]). Here we establish the endogenous relevance of vHP GHSR signaling to a specific component of feeding -- conditioned feeding. We hypothesize that pharmacologically induced hyperphagia following vHP ghrelin injections occurs, at least in part, by augmenting the saliency of conditioned food-relevant interoceptive stimuli and/or external cues that are present in the environment.

To investigate neural pathways downstream to vHP ghrelin-mediated feeding behavior, we focused on the dpLHA region that contains abundant ORX-expressing neurons ([@bib68]; [@bib26]), and provide evidence of an input to dpLHA ORX-expressing from GHSR-expressing neurons in the vHP (field CA1). Our data confirm the existence of an exclusively ipsilateral direct input to the dpLHA from the vHP field CA1, and further demonstrate that \~85% of vHP field CA1 neurons retrogradely labeled from the dpLHA are immunoreactive for GHSR. These findings suggest that vCA1 ghrelin-responsive neurons send a direct input to the dpLHA, thereby highlighting the dpLHA as a downstream target for vHP ghrelin-mediated feeding.

Based on research showing an extensive population of orexin producing neurons in the dpLHA ([@bib68]; [@bib26]; [@bib61]; [@bib11]), as well as functional and neuroanatomical interactions between ghrelin and Ox1R signaling ([@bib13]; [@bib48]; [@bib54]; [@bib66]; [@bib75]), we next investigated the relationship between vCA1 and dpLHA orexin neurons. A direct connection from the vHP to dpLHA neurons was confirmed by the presence of PHAL-immunoreactive axons in the dpLHA following vHP field CA1 PHAL injections. Several instances of PHAL-labeled axons with varicosities and terminal boutons were recorded in close apposition to dpLHA ORX-expressing neurons. Triple-labeling for PHAL, ORX and the presynaptic marker synaptophysin indicated that some of these close appositions were putative sites of synaptic input. Next, we tested whether vHP GHSR activation engages dpLHA orexin neurons. Immunohistochemical analysis of Fos and orexin expression in the dpLHA in rats treated with vHP ghrelin or vehicle injections revealed Fos expression in approximately 70% of dpLHA orexin-expressing neurons. Taken together, these findings indicate a functional pathway involving GHSR-expressing vHP field CA1 neurons and their downstream communication to dpLHA orexin neurons.

To investigate the functional relevance of a putative vHP field CA1 ghrelin to LHA orexin connection further, we combined behavioral neuropharmacology (vHP ghrelin injection) with an excitotoxic unilateral LHA lesion-mediated neural disconnection approach (adapted after \[[@bib57]\]). This approach takes advantage of an exclusively ipsilateral connection between the vHP and the LHA. Results show that vHP ghrelin administration ipsilateral to unilateral LHA lesions (vHP GHSR to LHA communication eliminated) blocks vHP ghrelin-activated hyperphagia that occurs in rats with sham lesions, and that also occurs when vHP ghrelin injections are given contralateral to the unilateral dpLHA lesion (vHP GHSR to LHA communication intact). These data indicate that vHP to dpLHA communication is critical for vHP ghrelin-mediated feeding effects.

A limitation in interpreting these findings with regard to the control of conditioned feeding behavior is that these experiments utilized pharmacological activation of vHP ghrelin receptors during free feeding conditions, and therefore the endogenous relevance of this neural circuitry during conditioned or entrained feeding requires further research. However, our data from Exp. 1 provide strong support for the endogenous relevance of vHP ghrelin signaling system for conditioned food intake. We hypothesize that the robust hyperphagic response following vHP GHSR activation during free feeding conditions is based, at least in part, on pharmacologically activating conditioned feeding behavior in the presence of food-associated cues. In other words, pharmacological vHP GHSR activation is potentially bolstering the saliency of internal (e.g., circadian, metabolic) or external cues within the animal's environment (e.g., food hopper) that have the capacity to promote feeding behavior based on learned associations with feeding. Consistent with this framework, vHP GHSR activation increases meal frequency in response to external environmental stimuli (auditory, visual) that were associated with palatable food access, whereas vHP ghrelin signaling does not augment feeding in response to control stimuli with no prior food association ([@bib37]). However, because present data do not directly assess the functional importance of vHP ghrelin to LHA orexin neural circuitry in conditioned feeding, we acknowledge that this pathway might also mediate aspects of non-conditioned appetite and feeding behavior. Indeed, ghrelin signaling in other brains regions appears to stimulate non-conditioned appetitive responding ([@bib64]; [@bib65]). For example, ICV or intra-amydala administration of the same GHSR antagonist used in this study (JMV2959) reduces free feeding in fasted (non-entrained) animals ([@bib63]; [@bib1]).

Neurons in the LHA also express GHSR, and LHA orexin-producing neurons are activated by external food-related cues as well as by direct LHA ghrelin administration ([@bib48]; [@bib55]). These findings suggest that in addition to the vHP, the LHA might also be a target for ghrelinergic conditioned feeding responses. However, our present data reveal that intra-LHA JMV2959 (including a dose that was effective in the vHP) had no effect on food intake in meal-entrained and non-meal-entrained animals, suggesting that while ghrelin signaling in various brain regions stimulates non-conditioned feeding behavior, vHP ghrelin signaling is a potentially unique neural substrate for learned aspects of feeding behavior. We note that it is also possible that vHP ghrelin to LHA orexin neural circuitry mediates non-conditioned aspects of feeding, however, this notion requires further investigation.

Our neuroanatomical data are consistent with previous research showing that vHP output to the LHA primarily targets the dpLHA region ([@bib26]; [@bib27]; [@bib39]) that was targeted with our unilateral NMDA lesions. While the anatomical and behavioral data in the current study suggest that vHP neurons communicate ghrelinergic signaling to the dpLHA directly, we recognize that multisynaptic pathways are also likely be involved. In addition to providing an input to the LHA, vHP field CA1 neurons also provide an input to several other feeding-related brain regions, including the amygdala and medial prefrontal cortex (mPFC) ([@bib35]; [@bib9]). These regions also provide a topographically organized input to the LHA ([@bib28]; [@bib27]), and neural connectivity between the amygdala-LHA and mPFC-LHA has been shown to be critical for conditioned cue-potentiated feeding ([@bib57]; [@bib56]). Additional studies are required to determine the functional relevance of these other pathways to vHP ghrelin-mediated appetite.

We examined the requirement of downstream Ox1R signaling for vHP ghrelin-mediated feeding effects, demonstrating that central Ox1R blockade (via LV injections of an Ox1R antagonist) attenuated the hyperphagic effects of vHP ghrelin signaling. However, because ventricular injections spread throughout the CNS and Ox1R s are expressed throughout the brain, ([@bib33]; [@bib44]), we can only speculate as to the mediating sites of Ox1R activation. Recent research has shown that blockade of Ox1Rs in the VTA attenuates food intake induced by LV ghrelin ([@bib13]). Given these findings, and the role of VTA dopaminergic signaling in various aspects of feeding behavior ([@bib13]; [@bib65]; [@bib47]; [@bib42]; [@bib46]; [@bib6]), we hypothesize that VTA Ox1R signaling is a critical downstream target of vHP ghrelin to dpLHA orexin signaling, however, this remains to be tested. Previous literature has also shown that central orexin signaling has roles in sleep/wake and arousal in addition to regulating feeding behavior ([@bib25]; [@bib10]). The current study did not directly assess the relationship between vHP ghrelin signaling and orexin mediated arousal. It is possible that the enhanced saliency of external food-related cues following vHP ghrelin signaling is mediated by increased arousal, as well as potential changes to circadian activity, from downstream activation of central Ox1R\'s (possibly in the locus coeruleus). Further studies are required to test these possibilities, as well as the role of downstream Ox1R signaling in other aspects of feeding behavior ([@bib81]; [@bib23]; [@bib80]; [@bib51]; [@bib30]; [@bib7]; [@bib72]; [@bib73]).

Based on the present results and the findings of related previous research, we propose the following model in which vHP ghrelin signaling engages conditioned feeding behavior ([Figure 9](#fig9){ref-type="fig"}): \[1\] Ghrelin is secreted from the stomach in response to cues (internal or external) related to meal anticipation, \[2\] Ghrelin crosses the blood brain barrier and enters the central nervous system, \[3\] vHP GHSR-expressing neurons are activated by ghrelin, \[4\] These vHP ghrelin-activated neurons engage downstream dpLHA orexin-expressing neurons, \[5\] Activation of this neural pathway increases appetite and feeding behavior. Together, our data highlight novel neurobiological mechanisms by which ghrelin engages higher-order brain circuitry, that in turn controls hypothalamic systems necessary for the regulation of appetite.10.7554/eLife.11190.013Figure 9.A model for vHP ghrelin-mediated conditioned feeding behavior.(**A**) Animals learn to anticipate a meal based on external or internal food cues. (**B,C**) Ghrelin secreted from the stomach in anticipation of feeding crosses the blood brain barrier and enters the central nervous system. (**D**) Ghrelin acts on GHSR in vHP neurons, which engages (**E**) Downstream activation of dpLHA orexin neurons and CNS Ox1R signaling. (**F**) Activation of this neural pathway increases conditioned appetite and feeding behavior.**DOI:** [http://dx.doi.org/10.7554/eLife.11190.013](10.7554/eLife.11190.013)

Materials and methods {#s4}
=====================

Animals {#s4-1}
-------

Male Sprague-Dawley rats (Harlan, Indianapolis, IN) (320--450 g) were individually caged in a temperature-controlled vivarium with unlimited access (except where noted) to water and food (LabDiet 5001, LabDiet, St. Louis, MO ) on either 12 hr:12 hr light/dark cycle (lights on at 8:00 AM) or 12:12 hr reverse light/dark cycle (lights off at 10:00AM). For all surgical procedures, rats were anesthetized (ketamine 90mg/kg and xylazine, 2.8 mg/kg), and sedated (acepromazine. 0.72 mg/kg). All procedures were approved by the Institute of Animal Care and Use Committee, at the University of Southern California.

Central drug injections, and excitotoxic (NMDA) lesions (Experiments 1, 3, 5 and 6) {#s4-2}
-----------------------------------------------------------------------------------

Experiments involving central drug injections were as follows: (Exp. 1) bilateral vHP injection of a ghrelin receptor (GHSR) antagonist (JMV2959, EMD Millipore, Billerica, MA); (Exp. 3) unilateral dpLHA injections of NMDA (Sigma-Aldrich, St. Louis, MO); (Exp. 3 and 5) unilateral vHP injection of ghrelin (Bachem, Torrance, CA); (Exp. 6) bilateral vHP injection of ghrelin and lateral ventricle injection of an orexin receptor type 1 (Ox1R) antagonist (SB334867, Tocris Bioscience, Ellisville, MO). Drugs were dissolved in artificial cerebrospinal fluid (aCSF), except SB334867 which was dissolved in DMSO.  Drugs were delivered using a microinfusion pump (Harvard Apparatus, Holliston, MA) connected to a 33-gauge microsyringe injector, via indwelling guide cannulae. Flow rate was calibrated and set to 5 µl/min; injection volume was 100 nl/hemisphere for Exp. 1, 3 and 6. Injection volume for NMDA lesions were 200 nl (dose: 4 μg). Ventricular injections in Exp. 6 were 1 ul in volume. Injectors were left in place for 30 sec post-injection.

Guide cannulae (26-gauge, Plastics One, Roanoke, VA) for bilateral vHP drug injections were implanted at the following stereotaxic coordinates ([@bib52]): -4.9 mm anterior/posterior (AP), 4.8 mm medial/lateral (ML), 6.1 mm dorsal/ventral (DV); they were then affixed to the skull with jewelers screws. Coordinates for lateral ventricular injections of Ox1R antagonist SB334867 were -0.9 mm AP, 1.8 mm ML, 2.6 mm DV. Coordinates for excitotoxic (4 ug, NMDA, 200 nl) LHA lesions, were -2.9 mm AP, 1.1 mm ML, -8.9 mm DV. Injectors for drug administration projected 2 mm beyond guide cannulae. Coordinates for LHA injections were -2.9 mm AP, +/- 1.0 mm ML, -6.7 mm DV. Placement of vHP and LHA cannulae placement was determined post-mortem by injection (via guide cannulae) of a blue dye (100 nl 2% pontamine sky blue ink). Data from animals with dye restricted to the vHP were included in the analysis (a representative vHP injection site is shown in [Figure 1](#fig1){ref-type="fig"}). In total, 12% of rats with vHP cannulae were excluded from the analysis because of misplaced cannulae, determined by the presence of blue dye as noted above.

The extent of unilateral NMDA dpLHA-targeted lesions was determined postmortem by immunohistochemical detection of the neuronal marker NeuN. Rats showing pronounced (65%) loss of NeuN labeling within the dpLHA compared to a contralateral sham (aCSF) injection in the same animal were included in data analysis (two rats with minimal or misplaced lesions were excluded).

Targeting of the OX1R antagonist SB334867 to the lateral ventricle (Exp. 6) was verified 1 week post-injection of the antagonist by elevation of cytoglucopenia resulting from injection (at the same coordinates) of 210 μg (2 μl) of 5-thio-D-glucose ([@bib59]). A post-injection elevation of at least 100% of baseline glycemia was required for subject inclusion (1 rat was excluded).

Neural pathway-tracing (Exp. 2 and 4) {#s4-3}
-------------------------------------

Experiments involving neural pathway-tracing were as follows: (Exp. 2) Retrograde tracing from the dpLHA following unilateral pressure injection of either Fluorogold (FG, Fluorochrome LLC, Denver, CO; 2% in 0.9% NaCl), or cholera toxin B subunit conjugated to (red fluorophore) Alexa Fluor 594 (CTB-AF594, 0.25% in 0.9% NaCl, Life Technologies, Carlsbad, CA; Cat. No. C-22842). Pressure injections were performed using a microinfusion pump as described above; injection volumes were 100 nl (Exp. 4). Anterograde tracing from the vHP field CA1 following unilateral iontophoretic injection of *Phaseolus vulgaris*-leucoagglutinin (PHAL, Vector Labs, Burlingame, CA; 2.5% in 0.1 M sodium phosphate-buffered saline, pH 7.4) was performed using a precision current source (digital midgard precision current source, Stoelting) as described previously ([@bib26]). PHAL immunoreactive axons in the LHA confirmed the exclusively ipsilateral nature of vHP to LHA projections ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}; representative vHP PHAL injection site, [Figure 6](#fig6){ref-type="fig"}).

Immunohistochemistry {#s4-4}
--------------------

Experiments 2--5 included immunohistochemical (IHC) analyses. Animals were anesthetized, then perfused transcardially with ice-cooled 0.9% saline, followed by 4% paraformaldehyde in 0.1 M borate buffer of pH 9.5. The brains were removed and immersed in the same (unused) fixative containing 12% sucrose for 20--24 hr at 4ºC. The brains were then blocked transversely at the level of the caudal midbrain, and each block was flash-frozen in dry-ice cooled hexane before being sectioned frozen on a sliding microtome (transverse plane, 30 µm thickness, 5 series). Sections were stored in antifreeze solution at -20°C until further processing (Antifreeze solution: 30% ethylene glycol, 20% glycerol in 0.02 M potassium phosphate-buffered saline---KPBS).

The following primary antibodies were used: (Exp. 2) anti-CTB (raised in goat) and anti-GHSR (goat); (Exp. 4) anti-PHAL (goat), anti-ORX1a (rabbit), and anti-synaptophysin (mouse); (Exp. 5) anti-cFos (sheep) and anti-ORX1a (rabbit). Antibody incubations were done at 4ºC (washes and other steps at room temperature). Primary antibody incubation was overnight (\~18 hrs). Primary antibodies were diluted in the following solution: KPBS containing 1% donkey serum and 0.1% Triton X-100; this step was followed by KPBS washes (8 changes, 10 mins each). Overnight secondary antibody incubation: Biotinylated secondary antibodies or secondary-fluorophore conjugates were diluted in KPBS containing 0.1% Triton X-100; this step was followed by KPBS washes (6 changes, 10 mins each). Overnight tertiary incubation (if biotinylated secondary antibodies were applied: Streptavdin-fluorophore conjugate was diluted in KPBS; this step was followed by KPBS washes (3 changes, 10 mins each). Sections were mounted onto glass slides, allowed to dry, and coverslipped, using 50% glycerol in KPBS mountant. Coverslip edges were sealed with clear nail polish.

Controls for IHC: For each primary antibody used, a standard control was performed in which the primary antibody was omitted from the protocol (to control for non-specific signal resulting from subsequent antibody and signal-detection reagents). In addition, for GHSR primary antibodies, an adsorption / neutralization was performed using the GHSR peptide sequence (a propriety sequence derived from a portion of the complete GHSR sequence). Following this adsorption, GHSR labeling was abolished. Photomicrographs were acquired using either a Nikon 80i and (Nikon DS-QI1,1280X1024 resolution, 1.45 megapixel) under epifluorescent illumination, or as optical slices using a Zeiss LSM 700 UGRB Confocal System (controlled by Zeiss Zen software). All photomicrographs in the figures are oriented such that: up = dorsal, down = ventral, left = medial, right = lateral.

Experiment 1: Effect of vHP-mediated ghrelin signaling on conditioned feeding behavior {#s4-5}
--------------------------------------------------------------------------------------

Rats were implanted bilaterally with vHP-targeted cannulae (n=11). After recovery from surgery, they were put on a meal-entrainment schedule where they were limited to food access for 4 hr daily, beginning at 10:00 AM (start of dark cycle), for 8 days. One day after the last training day, immediately prior to lights off, the meal-entrained rats were injected via their bilaterally implanted cannulae with either 0 µg, 1 µg, or 5 µg of a ghrelin receptor (GHSR) antagonist (JMV2959; total doses: 0 µg, 2 µg, 10 µg). Dose selection for JMV2959 was based on previous reports ([@bib64]; [@bib1]). Treatments were separated by 2--3 intervening day using a counterbalanced within-subjects design. Food intake was recorded 4 hr post-injection (food spillage accounted for). To control for the effects of vHP GHSR antagonism on food intake independent of meal-entrainment, 2 additional groups of rats (n=8/group) were 20 hr food deprived before receiving vHP injections of vehicle or JMV2959 (10 μg) and having their food intake recorded (as described above). A between-subjects design was used to avoid conditioning effects with repeated food restriction. Given the baseline differences in food intake between meal-entrained and control rats, to control for a lack of observable effects based on low kcal intake (i.e., floor effect) in controls, a separate cohort of non-food restricted rats (n=11) were first habituated to 1 \~3 g pellet of a 'Western diet' a day (45% kcal fat, enriched with sucrose; Research Diets D12451) for 5 days, given at random times to avoid conditioning effects. Two days later, animals received vHP injections of 0 µg, 1 µg, or 5 µg JMV2959 (total doses: 0 µg, 2 µg, 10 µg) using a counter-balanced within subjects design (treatments separated by 2--3 intervening days) and food intake was recorded as described above.

To determine whether endogenous LHA ghrelin signaling also contributes to conditioned feeding responses, we repeated the meal entrainment (n=9) and non-entrained, 20 hr food deprivation (n=15) procedures described above with bilateral, intra-LHA injections of JMV2959 (total doses: 0 μg, 2 μg, 10 μg).

Experiment 2: Investigation of dorsal perifornical LHA (dpLHA) input from vHP GHSR-expressing neurons {#s4-6}
-----------------------------------------------------------------------------------------------------

Each rat (n=6) received a unilateral injection of CTB and a unilateral contralateral injection of FG targeted to the dorsal perifornical LHA (dpLHA). Seven days later, rats were fixation-perfused, and brains removed and processed as described. Fluorogold was examined using its native fluorescence. Detection of CTB by IHC followed the steps described above, except the following antibodies and fluorophores were used: anti-CTB primary antibody (mouse monoclonal, 1:500, Abcam, Cambridge, MA Catalog \#ab62429); biotinylated anti-mouse secondary antibody (1:500, donkey polyclonal, Jackson Immunoresearch, West Grove, PA); streptavidin DyLight 549 tertiary reagent (1:500, Jackson Immunoresearch; overnight). For IHC detection of GHSR the following antibodies were used: Anti-GHSR1 primary antibody (goat, polyclonal; 1:500, Santa Cruz, Santa Cruz, CA, Catalog \#sc-10362); anti-goat Alexa Fluor 488 secondary antibody (donkey polyclonal, 1:500, Jackson Immunoresearch).

Experiment 3: Effects of excitotoxic (NMDA) dorsal perifornical LHA lesions on vHP ghrelin-mediated feeding {#s4-7}
-----------------------------------------------------------------------------------------------------------

Rats received unilateral NMDA injections targeted to the dpLHA (n=10) or sham lesions (n=7) and cannulae targeting the bilateral vHP. 2 hr into the rats light cycle (lights on at 8 AM), 0 pmol or 300 pmol ghrelin was administered to the vHP ipislateral to the dpLHA lesion. Unilateral ghrelin doses were determined based on pilot studies (data not shown) and previous literature ([@bib37]), where the maximally effective dose for hyperphagia was chosen. In a separate experiment, the same cohort received 0 pmol or 300 pmol ghrelin to the vHP contralateral to the dpLHA lesion. Treatments were separated by intervening 1 day using a counterbalanced mixed design, with sham or lesion as a between-subjects variable, and drug as within-subjects. Chow intake was recorded at 1, 3, and 5 hr after injections (food spillage accounted for).

Experiment 4: vHP output to orexin-expressing dpLHA neurons {#s4-8}
-----------------------------------------------------------

Rats (n = 4) received iontophoretic injections of PHAL targeting the vHP. Seven days later, the rats were euthanized and tissue was harvested and processed according to procedures outlined in *Materials and methods*. IHC detection of PHAL proceeded according to the above described procedures using goat anti-PHAL primary antibody (1:5000, Vector Labs, Catalog \#AS-2224), followed by a donkey anti-goat secondary antibody conjugated to Cy3 (1:500, Jackson Immunoresearch, 4 hr). Material from the experiment with a PHAL injection site that was most restricted to the vHP field CA1 region of interest was selected for subsequent IHC analysis of vHP connection interactions with dpLHA orexin neurons. IHC detection of orexin was performed as described using a rabbit anti-ORX1 primary antibody (1:1000, Phoenix Pharmaceuticals, Burlingame, CA; Catalog \#H-003-30, 18 hr), was followed bya donkey anti-rabbit secondary antibody conjugated to AMCA (1:500, Jackson Immunoresearch,).

IHC detection of synaptophysin was performed as described using a mouse anti-synaptophysin primary antibody (1:1000, PROGEN Biotechnik, Heidelberg, Germany; Catalog \#61012, 18 hr in room temperature), followed by a donkey anti-mouse secondary antibody conjugated to Alexa Fluor 488 (1:500, Jackson Immunoresearch).

Experiment 5: Effects of vHP ghrelin injection on Fos expression in orexin-expressing LHA neurons {#s4-9}
-------------------------------------------------------------------------------------------------

Rats received either unilateral vHP ghrelin (n=5; 300 pmol) or aCSF vehicle injections (n=4). 60 min later, animals were euthanized and tissue was harvested and processed according to procedures outlined in *Materials and methods*.

Fos was used as a marker for neuronal activity, and IHC detection was performed according to the procedure above using a sheep anti-Fos primary antibody (1:2000, Cell Signaling, Danvers, MA; Catalog \# 2250s, 18 hr), followed by a donkey anti-goat secondary antibody conjugated to Alexa Fluor 488 (1:500, Jackson Immunoresearch, 4 hr).

IHC detection of orexin was performed as above using a rabbit anti-Ox1a primary antibody (1:1000, Phoenix Pharmaceuticals, Catalog \#H-003-30, 18 hr) and was followed up with an incubation of a donkey anti-rabbit secondary antibody conjugated to Cy3 (1:500, Jackson Immunoresearch).

Quantification of co-localization of Fos and orexin positive cells was calculated by an experimenter blind to the treatment conditions using ImageJ software (cell count Plugin) based on the number of co-localized Fos and orexin cells divided by the total number of orexin positive cells.

Experiment 6: Effect of introcerebroventricular injection of an OX1R antagonist on vHP ghrelin induced feeding. {#s4-10}
---------------------------------------------------------------------------------------------------------------

Rats (n=15) received cannulae targeting the both the vHP and LV. 2 hr into light cycle, animals received LV injections of 0 nmol or 30 nmol the orexin-1 receptor antagonist, SB334867, immediately followed by 0 pmol or 300 pmol ghrelin to the vHP. Dose of SB334867 was determined based on previous literature ([@bib51]; [@bib31]). Treatments were separated by 1 intervening day using a counterbalanced within-subjects design. Chow intake was measured 1, 3, and 5 hr after injections (food spillage accounted for).

Statistical analysis {#s4-11}
--------------------

All statistical analyses employed repeated measures or one-way analysis of variance (ANOVA). The α level for significance was 0.05. Statistical analyses were conducted with computer software (Statistica V7; Statsoft). To ensure the minimum sample size required to be reasonably likely to detect the hypothesized effect, power analyses were conducted for each proposed experiment based on our pilot and recently published experiments using Statsoft software (Statistica 64, V7). Alpha level was set at 0.05 for power analyses; the Root Mean Square Standardized Effect (RMSSE) was estimated separately for each experiment
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Thank you for submitting your work entitled \"Hippocampus ghrelin signaling mediates conditioned appetite through lateral hypothalamic orexin pathways\" for peer review at *eLife*. Your submission has been favorably evaluated by a Senior editor, a Reviewing editor, and two reviewers.

The reviewers have discussed the reviews with one another and the Reviewing editor has drafted this decision to help you prepare a revised submission.

This paper describes a neural circuit from ventral hippocampus to the orexin neurons in the lateral hypothalamus that controls conditioned feeding responses.

Both reviewers indicated considerable enthusiasm for this paper; however they both suggested a few changes that would enhance its impact. The most critical concern is that the title and beginning of Results indicate that hippocampal ghrelin signaling is important for \'conditioned feeding\' but not for ad lib feeding or feeding after a fast. The title also implicates the circuit from the hippocampus to the orexin neurons in the lateral hypothalamus as being involved in \'conditioned feeding\' but those studies did not use the conditioned feeding paradigm. The authors need to include data for the \'conditioned feeding\' paradigm in their experiments \#3 and \#6 if they want to make the claims proposed in title and Abstract. If the authors want to broaden the role of ghrelin acting on the \'hippocampus to orexin neuron circuit\' to mediate many aspects a feeding, then they should compare the relative importance of hippocampal input to orexin neurons with other potential inputs (reviewer \#2 comment 3). The authors should also address the other concerns raised by the reviewers.

Minor comment from the Reviewing editor: It is customary to put a space between numbers and units, e.g. 4 hr, not 4 hr. Also, abbreviations should be used consistently, e.g. in the first paragraph of Results, we see 4 hr and 4h food intake. Finally, there is only one Fos gene in the rat, so there is no need to distinguish c-Fos from v-Fos (which is of viral origin); i.e., Fos is sufficient.

*Reviewer \#1:*

In this study entitled \"Hippocampus ghrelin signaling mediates conditioned appetite through lateral hypothalamic orexin pathways\", by Ted M Hsu and colleagues describe a new neuronal circuit mediating ghrelin-induced eating, with a focus on the effects of ghrelin on meal-entrained food intake. Using several classical neuroanatomical techniques, including histochemistry, targeted stereotaxic injections, anterograde and retrograde tracing, and brain site lesioning in rats, the investigators now describe a pathway in which GHSR-expressing ventral hippocampal neurons from the CA1 region project to ipsilateral dpLHA orexin neurons. When activated by ghrelin, this pathway results in ghrelin-induced food intake.

This paper is strong for several reasons:

1\) Theme: While the hippocampus has been described before as playing a role in various aspects of ghrelin action, the neuronal circuits within which ghrelin-responsive hippocampal neurons participate have not been known. This study describes for the first time a ghrelin-responsive neuronal circuit involving the hippocampal neurons.

2\) Technique: The neuroanatomical techniques utilized are classic and performed elegantly.

A major comment follows, although it should not require any major changes to address: The investigators frame this work and this pathway as all being relevant to 'conditioned feeding' which they model with about a week of restricted access to food for only 4 hr per day. However, I think it is premature with the data provide to attribute this pathway as being relevant specifically to their model of conditioned feeding. Only in the experiments summarized in [Figure 2](#fig2){ref-type="fig"} was the meal entrainment done -- and for those experiments, injections of a GHSR antagonist directly into the vHP were used to confirm that GHSR-expressing vHP neurons were important for conditioned feeding (but not for 4 hr rebound feeding following a 20 hr food restriction). In the subsequent experiments, neuroanatomic techniques were used to track the projections of GHSR-expressing/ghrelin-responsive neurons to the LHA. Also, the orexigenic effects of pharmacologic ghrelin-injections into the vHP were assessed in LHA-lesioned animals or Orexin receptor blocker-administered animals. Activation of LHA neurons was also assessed in animals administered ghrelin into the vHP. Thus, while GHSR-expressing vHP neurons appear to be important for conditioned feeding, the GHSR-expressing vHP neurons projecting to the LHA orexin neurons are not necessarily involved in that particular aspect of ghrelin-induced eating. Thus, the possible role of this newly described pathway in a broader scope of ghrelin\'s many feeding-related actions should be mentioned. If the investigators want to limit this pathway to conditioned feeding, further physiologic experiments would be needed -- e.g., inhibit downstream portions of that pathway and determine how it affects conditioned feeding.

*Reviewer \#2:*

The set of studies presented here are important in addressing the neurobiological substrates of overeating in today\'s society -- where consumption is rarely triggered by caloric deficit. They are also important in elucidating an under-appreciated node for the regulation of feeding -- the vHP. The work is well conducted and thorough. The authors provide ample data to support most of their conclusions. I have three major comments that need to be addressed:

1\) A key argument, and the title of the paper, posits that ghrelin action in the ventral hippocampus augments the conditioned aspects of feeding through LH orexin neurons. A limitation of the manuscript is that the authors do not actually show this. First, they show that hippocampal ghrelin augments conditioned bouts of feeding. They then go on to show that hippocampal ghrelin increases unconditioned food intake and this requires an intact ipsilateral LH ([Figure 5](#fig5){ref-type="fig"}) and the availability of central orexin receptors ([Figure 8](#fig8){ref-type="fig"}). However, the authors do not show that central orexin receptors are required for ventral hippocampal ghrelin to augment conditioned feeding. Repeating the approach in [Figure 1](#fig1){ref-type="fig"} but infusing either vehicle or the SB334867 into the lateral ventricle would solidify the argument. The use of an orexin saporin for a selective LH lesion would also solidify the argument.

2\) In [Figure 5](#fig5){ref-type="fig"}, the authors compare food intake induced by vHP ghrelin (or vehicle) in animals with (or without) LH lesions. They compare these groups separately according to whether or not the animals had an LH lesion or sham ([Figure 5](#fig5){ref-type="fig"}). These data should be combined and compared using an ANOVA with main effects of surgery (Lesion, Sham) and treatment (Vehicle, Ghrelin). This comparison will help parse out any non-specific effects of the LH lesion unrelated to ghrelin treatment. Moreover, this is critical because bilateral LH lesions are well known to alter feeding behavior and it appears there are differences in the amount of food consumed between the lesion and sham animals that received vehicle. For example, compare food intake vehicle treated animals in lesion and sham groups at 1 hr and 5 hr.

3\) The authors are very thoughtful in their Discussion. However, if the authors posit that the source for vHP GHSR activation is peripheral ghrelin evoked by interoceptive or external cues then GHSRs are likely to be activated in other brain regions where they are expressed -- including LHA GHSRs. LHA orexin neurons express GHSRs and are activated by cues. While the authors are to be commended for showing that vHP GHSRs are required for the full expression of conditioned feeding in the present paradigm -- supporting an endogenous roll for ghrelin in the vHP, the manuscript would be strengthened by investigating another GHSR-rich region to determine if similar effects are observed or whether the GHSRs in the vHP uniquely participated in meal-entrained conditioned feeding. At the very least, this unresolved issue should be discussed.
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Author response

*\[...\] Both reviewers indicated considerable enthusiasm for this paper; however they both suggested a few changes that would enhance its impact. The most critical concern is that the title and beginning of Results indicate that hippocampal ghrelin signaling is important for \'conditioned feeding\' but not for ad lib feeding or feeding after a fast. The title also implicates the circuit from the hippocampus to the orexin neurons in the lateral hypothalamus as being involved in \'conditioned feeding\' but those studies did not use the conditioned feeding paradigm. The authors need to include data for the \'conditioned feeding\' paradigm in their experiments \#3 and \#6 if they want to make the claims proposed in title and Abstract.*

We thank the reviewers for bringing this concern to our attention. We acknowledge the possibility that the hippocampal ghrelin to lateral hypothalamic orexin circuit could potentially be involved in aspects of appetite and feeding behavior other than conditioned feeding. We further agree that the data presented in Exp. 3 and 6 do not directly assess the importance of this circuit in conditioned feeding. To address this issue, we considered repeating the conditioned feeding paradigm using designs parallel to Exps. 3 and 6, however, we note that the animals are robustly hyperphagic during 20 hr food restricted meal entrainment conditions, and thereby activation of vHP ghrelin receptors would be unlikely to augment intake from a high baseline of excessive food intake (i.e., ceiling effect). Moreover, an antagonist approach for the ghrelin receptor in Exps. 3 and 6 is not logical since these studies are designed to investigate downstream pathways.

Nevertheless, we agree that our previous manuscript draft did not sufficiently consider a role for vHP ghrelin in other (e.g., non-conditioned) aspects of appetite and feeding. Accordingly, we have revised the title and Abstract, extended our Discussion, and modified the overall language throughout the manuscript to reflect a broader discussion of the role of ghrelin signaling in the hippocampus and elsewhere in the brain in many aspects of feeding behavior. For example, our title now reads, \"Hippocampus ghrelin signaling mediates appetite through lateral hypothalamic orexin pathways\", and \"learned feeding aspects of feeding behavior\" was explicitly removed from the Abstract. Other instances include the Introduction and Discussion (end of last three paragraphs). While we retain the viewpoint that hippocampal ghrelin signaling is critical for conditioned feeding (based on Exp.1), in this revised manuscript, we do not disregard the possibility of the vHP-LHA circuitry as being involved in a variety of other food-motivated behaviors. Overall our extended discussion uses a more cautious tone with regards to vHP ghrelin having an exclusive role in conditioned feeding.

*If the authors want to broaden the role of ghrelin acting on the \'hippocampus to orexin neuron circuit\' to mediate many aspects a feeding, then they should compare the relative importance of hippocampal input to orexin neurons with other potential inputs (reviewer \#2 comment 3). The authors should also address the other concerns raised by the reviewers.*

As specifically suggested by Reviewer \#2 we have added an additional experiment which compares the relative importance of hippocampal GHSR mediated conditioned feeding with another GHSR rich region, the lateral hypothalamus (LHA). As stated by Reviewer \#2, the LHA contains orexin producing neurons that are activated by both LHA ghrelin infusion and by external food-related cues (Olszewski et al., 2003; Petrovich et al. 2012). Moreover, LHA ghrelin infusion (like vHP ghrelin infusion) increases food intake in rats (Olszewski et al., 2003). Therefore, the LHA is a logical additional target of potential importance for ghrelin-mediated conditioned feeding effects. Our new experiment replicates Exp.1, except that the GHSR-1A receptor antagonist, JMV2959, is now administered bilaterally to the LHA in meal-entrained animals and non-entrained animals (20 hr food deprived). We have included this new experiment in the manuscript, and the results (described in subsection "Endogenous ghrelin signaling in LHA neurons does not regulate conditioned feeding behavior") are displayed in [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}. Our results show that GHSR blockade using a dose of JMV2959 that was effective in the vHP had no effect on entrained food intake or non-entrained food intake in similarly food-restricted animals. These findings suggest that vHP ghrelin signaling is particularly critical in the expression of conditioned feeding behavior based on internal (or potentially external) contextual cues, whereas LHA ghrelin signaling could be mediating other aspects of appetite and feeding. In this revised manuscript we now further elaborate in the Discussion on the feeding effects of ghrelin in brain regions such as the lateral hypothalamus, ventral tegmental area, and amygdala (Olszewski et al., 2003;, Perello et al., 2010; Skibicka et al., 2011; Alvarez-Crespo et al., 2012) as well as other feeding effects of downstream orexin signaling (Zhu et al., 2002; Goforth et al., 2014; Zheng et al., 2007; Parise et al., 2011; Harris et al., 2005; Thorpe et al., 2005; Thorpe et al., 2006). The specific mechanisms underlying LHA ghrelin mediated feeding will require further studies beyond the scope of this manuscript, but we believe that this additional experiment adds further support for the importance of vHP GHSR-1A signaling specifically in mediating conditioned feeding effects and improves the overall quality of the manuscript.

Minor comment from the Reviewing editor: It is customary to put a space between numbers and units, e.g. 4 hr, not 4 hr. Also, abbreviations should be used consistently, e.g. in the first paragraph of Results, we see 4 hr and 4h food intake. Finally, there is only one Fos gene in the rat, so there is no need to distinguish c-Fos from v-Fos (which is of viral origin); i.e., Fos is sufficient.

We thank you for the suggestion. Accordingly, we have now added spaces between numbers and units and we have corrected for consistency in abbreviations throughout the manuscript. We appreciate your suggestion regarding the 'Fos' abbreviation, but we have opted to stick with the 'c-Fos' abbreviation, as we are aware of reports indicating that the rat brain also expresses $\text{Δ}$FosB (Hollen et al., 1997).

Reviewer \#1:

*\[...\] A major comment follows, although it should not require any major changes to address: The investigators frame this work and this pathway as all being relevant to 'conditioned feeding' which they model with about a week of restricted access to food for only 4 hr per day. However, I think it is premature with the data provide to attribute this pathway as being relevant specifically to their model of conditioned feeding. Only in the experiments summarized in [Figure 2](#fig2){ref-type="fig"} was the meal entrainment done -- and for those experiments, injections of a GHSR antagonist directly into the vHP were used to confirm that GHSR-expressing vHP neurons were important for conditioned feeding (but not for 4 hr rebound feeding following a 20 hr food restriction). In the subsequent experiments, neuroanatomic techniques were used to track the projections of GHSR-expressing/ghrelin-responsive neurons to the LHA. Also, the orexigenic effects of pharmacologic ghrelin-injections into the vHP were assessed in LHA-lesioned animals or Orexin receptor blocker-administered animals. Activation of LHA neurons was also assessed in animals administered ghrelin into the vHP. Thus, while GHSR-expressing vHP neurons appear to be important for conditioned feeding, the GHSR-expressing vHP neurons projecting to the LHA orexin neurons are not necessarily involved in that particular aspect of ghrelin-induced eating. Thus, the possible role of this newly described pathway in a broader scope of ghrelin\'s many feeding-related actions should be mentioned. If the investigators want to limit this pathway to conditioned feeding, further physiologic experiments would be needed -- e.g., inhibit downstream portions of that pathway and determine how it affects conditioned feeding.*

We thank the reviewer for emphasizing an important caveat in our study; that vHP ghrelin to LHA neural circuitry could potentially mediate other aspects of feeding and appetite. We now take an overall more cautious approach regarding vHP ghrelin's role in feeding as being exclusive to conditioned aspects. We have expanded our discussion of this novel vHP-\>LHA pathway to include the putative involvement of other (non-conditioned) aspects of feeding behavior. In addition, we have altered the title and Abstract to reflect this more cautious perspective. Please see above (response to Reviewing Editor) where we expand on how we address this caveat in this revision, and where we also explain the conceptual difficulties inherent in expanding Exps. 3 and 6 to include conditioned feeding models.

Reviewer \#2:

*The set of studies presented here are important in addressing the neurobiological substrates of overeating in today\'s society -- where consumption is rarely triggered by caloric deficit. They are also important in elucidating an under-appreciated node for the regulation of feeding -- the vHP. The work is well conducted and thorough. The authors provide ample data to support most of their conclusions. I have three major comments that need to be addressed: 1) A key argument, and the title of the paper, posits that ghrelin action in the ventral hippocampus augments the conditioned aspects of feeding through LH orexin neurons. A limitation of the manuscript is that the authors do not actually show this. First, they show that hippocampal ghrelin augments conditioned bouts of feeding. They then go on to show that hippocampal ghrelin increases unconditioned food intake and this requires an intact ipsilateral LH ([Figure 5](#fig5){ref-type="fig"}) and the availability of central orexin receptors ([Figure 8](#fig8){ref-type="fig"}). However, the authors do not show that central orexin receptors are required for ventral hippocampal ghrelin to augment conditioned feeding. Repeating the approach in [Figure 1](#fig1){ref-type="fig"} but infusing either vehicle or the SB334867 into the lateral ventricle would solidify the argument. The use of an orexin saporin for a selective LH lesion would also solidify the argument.*

We appreciate the reviewer for highlighting this limitation with the manuscript and for providing suggestions to enhance the paper. Please see above (response to the Reviewing Editor) for our rationale regarding the conceptual difficulty involved with repeating the experiments from [Figures 5 and 8](#fig5 fig8){ref-type="fig"} using a conditioned feeding approach. Thus, as an alternative to address this caveat, we have now stressed throughout this revised manuscript that while vHP ghrelin signaling has important roles in conditioned feeding, it may well be the case that vHP ghrelin to LHA orexin neural circuitry has broader roles in feeding behavior, particularly given that orexin signaling and the LHA neural processing are involved in several aspects of feeding behavior (Zhu et al., 2002; Goforth et al., 2014; Zheng et al., 2007; Parise et al., 2011; Harris et al., 2005; Thorpe et al., 2005; Thorpe et al., 2006), (Stanley et al., 2011; Jennings et al., 2013; Legrand et al., 2015; Cason and Aston-Jones, 2013). Overall, in this revision we now take a more cautious approach towards attributing this circuit with an exclusive role in conditioned feeding, and we have altered the title, Abstract, and Discussion accordingly.

Regarding your suggestion to repeat the approach in [Figure 1](#fig1){ref-type="fig"} with LV SB334867, this is an interesting idea but we do not think that such an approach is feasible as it would require an orexigenic agonist (vHP ghrelin) application under conditions of excessive feeding. In other words, in our meal entrainment schedule, the rats are robustly hyperphagic during the 4 hr food access period, and thereby activation of vHP ghrelin receptors would be unlikely to augment intake from a high baseline of excessive food intake (i.e., ceiling effect).

*2) In [Figure 5](#fig5){ref-type="fig"}, the authors compare food intake induced by vHP ghrelin (or vehicle) in animals with (or without) LH lesions. They compare these groups separately according to whether or not the animals had an LH lesion or sham ([Figure 5](#fig5){ref-type="fig"}). These data should be combined and compared using an ANOVA with main effects of surgery (Lesion, Sham) and treatment (Vehicle, Ghrelin). This comparison will help parse out any non-specific effects of the LH lesion unrelated to ghrelin treatment. Moreover, this is critical because bilateral LH lesions are well known to alter feeding behavior and it appears there are differences in the amount of food consumed between the lesion and sham animals that received vehicle. For example, compare food intake vehicle treated animals in lesion and sham groups at 1 hr and 5 hr.*

We thank the reviewer for bringing our attention to this important matter. It was an oversight to omit this important statistical analysis from our previous submission, and we have now included the analysis in accordance with the reviewers; suggestion. After performing an ANOVA with group as a between subjects factor and drug as a repeated measures factor, we found no overall significant group effect on food intake at any time point. Importantly, we did obtain a significant interaction between group and drug at the 5 hr time point of food intake, and marginal significance for this interaction at 1 hr and 3 hr. This analysis is now added to the results of Exp.3 (subsection "Endogenous ghrelin signaling in LHA neurons does not regulate conditioned feeding behavior").

*3) The authors are very thoughtful in their Discussion. However, if the authors posit that the source for vHP GHSR activation is peripheral ghrelin evoked by interoceptive or external cues then GHSRs are likely to be activated in other brain regions where they are expressed -- including LHA GHSRs. LHA orexin neurons express GHSRs and are activated by cues. While the authors are to be commended for showing that vHP GHSRs are required for the full expression of conditioned feeding in the present paradigm -- supporting an endogenous roll for ghrelin in the vHP, the manuscript would be strengthened by investigating another GHSR-rich region to determine if similar effects are observed or whether the GHSRs in the vHP uniquely participated in meal-entrained conditioned feeding. At the very least, this unresolved issue should be discussed.*

We thank the reviewer for this suggestion. We agree that ghrelin signaling in different brain regions likely produces diverse effects on feeding behavior, which has prompted us to perform your suggested experiment: examining another GHSR-rich region (the LHA) and its function in conditioned feeding. We administered the ghrelin receptor antagonist JMV2959 in the LHA (using a dose that was effective in the vHP for reducing meal-entrained intake) in both meal-entrained and non-entrained (20 hr restricted) animals. Our results from this new experiment are displayed in [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"} (please also see "Experiment 1: Effect of vHP-mediated ghrelin signaling on conditioned feeding behavior", in the Methods, and "Endogenous ghrelin signaling in LHA neurons does not regulate conditioned feeding behavior", in the Results). We found that LHA GHSR blockade had no effects on food intake in meal entrained and non-meal entrained animals under the same deprivation conditions, using an identical design as experiment 1. These data suggest that ghrelin signaling in the LHA is not involved in conditioned feeding, (or at least to a lesser extent than the vHP) and may potentially have a broader and/or fundamentally different role in feeding behavior. Further assessment of LHA ghrelin mediated feeding behavior is beyond the scope of this manuscript and will require future experiments. Importantly, the notion that vHP ghrelin signaling is uniquely involved in conditioned feeding remains supported by the new data set, yet we still take a more cautious tone regarding this perspective in the revised manuscript.

Following the reviewers' suggestion, we have also expanded the Discussion to now address the role of ghrelin signaling in different brain regions as being involved different aspects of feeding (Sibicka et al., 2011; Sibicka et al., 2013). We now highlight two studies in which ICV (Salome et al., 2009) or intra-amygdala administration of JMV2959 (Alvarez-Crespo et al., 2012) reduces feeding in fasted (non-entrained) rats. Taken together, our study adds a novel perspective of ghrelin signaling in the brain by highlighting dissociative feeding effects of ghrelin depending on brain region.
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